This is a blend. GHK-Cu and BPC-157 are combined in a single 60 mg vial, 50 mg and 10 mg respectively. Both are studied in tissue and matrix models from different mechanistic angles: GHK-Cu is a naturally occurring copper-binding tripeptide characterised for collagen-synthesis and matrix endpoints, while BPC-157 is a synthetic 15 amino acid sequence characterised in preclinical models for angiogenesis and tissue remodelling. The combination has not been characterised as a single formulation.
The numbers that define GHK-Cu / BPC-157 and how it is being studied. For laboratory research use only.
2
Research Peptides
GHK-Cu · BPC-157
60 mg
Total Per Vial
50 mg GHK-Cu + 10 mg BPC-157
1973
GHK-Cu Isolated
From human plasma
4
Research Areas
Matrix remodelling
Collagen synthesis
Angiogenesis
How It Works
How GHK-Cu / BPC-157 works
The pathways GHK-Cu / BPC-157 acts on - and what each one does. The animation traces its signal outward from the compound to every target it engages.
Signalling pathways studied in preclinical models · illustrative
Copper Coordination
GHK-Cu
GHK-Cu is a tripeptide that binds copper(II). Collagen synthesis and extracellular-matrix endpoints are the characterised readouts in dermal research models.
Copper(II) coordination
Collagen synthesis endpoints
Matrix remodelling readouts
Preclinical Remodelling
BPC-157
BPC-157 copies part of a protein found in gastric fluid. Preclinical models have measured new blood vessel growth, tendon cell migration and tissue remodelling after injury.
Angiogenesis endpoints
Tendon cell migration
Stable in acidic conditions
Two Matrix Angles
Combined
The vial pairs a copper-coordinating tripeptide with a synthetic pentadecapeptide. The two are characterised separately and no interaction data exists for the pair.
Copper and peptide arms
Matched handling
Interaction not characterised
Uses & Applications
What GHK-Cu / BPC-157 is researched for
The main areas GHK-Cu / BPC-157 is being studied for - and the study-reported figures behind them.
Dermal
Matrix Research
GHK-Cu is among the more extensively characterised peptides in dermal research.
Cell Biology
Angiogenesis Models
BPC-157 has been measured for new blood vessel growth in preclinical models.
Cell Biology
Cell Migration
Tendon cell movement and spreading are documented BPC-157 endpoints.
Methods
Parallel Protocols
One vial holds both peptides under matched handling.
Study-reported magnitudes
Representative figures from published research. Bars fill as you scroll.
GHK-Cu Collagen EndpointsWell characterised
BPC-157 Preclinical ModelsCharacterised
Matrix Remodelling ReadoutsMeasured
Blend Interaction DataNone
Figures are representative of published research findings and shown for reference.
Molecular Structure
The GHK-Cu / BPC-157 molecule
An interactive 3D model rendered from the compound record - rotate and explore its structure.
Molecular model
Sequence length
blend
Physical form
Lyophilized powder blend
Documented purity
≥99% by HPLC
Compound Information
Full specification
Components
GHK-Cu + BPC-157
Content
60 mg per vial (50 mg GHK-Cu, 10 mg BPC-157)
GHK-Cu
Gly-His-Lys-Cu(II), CAS 49557-75-7
BPC-157
Synthetic pentadecapeptide, CAS 137525-51-0
Form
Lyophilized powder blend
Purity
≥99% by HPLC
Appearance
Blue to blue-grey powder (copper complex)
Solubility
Water-soluble
Storage
-20°C, protected from light
Classification
Research use only
FAQ
Common questions about GHK-Cu / BPC-157
Both are studied in tissue and matrix models but by different mechanisms: GHK-Cu through copper coordination and collagen-synthesis endpoints, BPC-157 through angiogenesis and remodelling endpoints in preclinical models. One vial holds both under matched handling.
GHK-Cu is a copper(II) complex, and copper complexes of this type are blue to blue-grey. At 50 mg of the 60 mg total it dominates the appearance of the blend.
No. Each peptide is characterised separately and no interaction data exists for the pair.
The separate products let you control each peptide quantity independently. This vial fixes the ratio at 50 mg and 10 mg.
Each lot is analysed by reverse-phase HPLC and released at ≥99%, with a Certificate of Analysis.
Store lyophilized at -20°C for long-term stability, protected from light and moisture, and avoid repeated freeze-thaw cycles.
Research Use Only.
Not for human or veterinary use. For in-vitro laboratory research only. These statements have not been evaluated by the FDA; this product is not intended to diagnose, treat, cure, or prevent any disease. Sold exclusively to qualified researchers and institutions.
